Douma, J.A.J.; Buffart, L.M.; Sedhom, R.; Labots, M.; Menke-van der Houven van Oordt, W.C.; Skardhamar, M.; De Felice, A.; Lee, E.; Dharmaraj, D.; Azad, N.S.;
et al. Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology. Cancers 2021, 13, 2304.
https://doi.org/10.3390/cancers13102304
AMA Style
Douma JAJ, Buffart LM, Sedhom R, Labots M, Menke-van der Houven van Oordt WC, Skardhamar M, De Felice A, Lee E, Dharmaraj D, Azad NS,
et al. Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology. Cancers. 2021; 13(10):2304.
https://doi.org/10.3390/cancers13102304
Chicago/Turabian Style
Douma, Joeri A. J., Laurien M. Buffart, Ramy Sedhom, Mariette Labots, Willemien C. Menke-van der Houven van Oordt, Mikkjal Skardhamar, Anthony De Felice, Esther Lee, Divya Dharmaraj, Nilofer S. Azad,
and et al. 2021. "Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology" Cancers 13, no. 10: 2304.
https://doi.org/10.3390/cancers13102304
APA Style
Douma, J. A. J., Buffart, L. M., Sedhom, R., Labots, M., Menke-van der Houven van Oordt, W. C., Skardhamar, M., De Felice, A., Lee, E., Dharmaraj, D., Azad, N. S., Carducci, M. A., & Verheul, H. M. W.
(2021). Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology. Cancers, 13(10), 2304.
https://doi.org/10.3390/cancers13102304
